Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Mount Sinai Faculty Practice Associates
5 East 98th ST. 11th FL
New York, NY 10029Phone+1 212-241-4060Fax+1 212-241-8488
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Glomerular Diseases, 2007 - 2008
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Nephrology, 2003 - 2005
- Yale-New Haven Medical CenterChief Residency, Internal Medicine, 2002 - 2003
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1999 - 2002
- Icahn School of Medicine at Mount SinaiClass of 1999
Certifications & Licensure
- NY State Medical License 2003 - 2026
- CT State Medical License 2003 - 2004
Awards, Honors, & Recognition
- Teaching Attending of the Year award Mount Sinai Nephrology Fellows, 2019
- Teaching Attending of the Year Award Mount Sinai Nephrology Fellowship, 2018
- Resident Report Attending of the Year Award Cornell Internal Medicine Residency, 2016
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsReport of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine.Fadi Salem, Joshua L. Rein, Samuel Mon-Wei Yu, Mathew Abramson, Paolo Cravedi
Kidney International Reports. 2021-07-27 - 46 citationsIgA Nephropathy After SARS-CoV-2 Vaccination.Matthew Abramson, Samuel Mon-Wei Yu, Kirk N. Campbell, Miriam Chung, Fadi Salem
Kidney Medicine. 2021-07-14 - 32 citationsRituximab Treatment of Fibrillary GlomerulonephritisMichael P. Collins, Sankar D. Navaneethan, Miriam Chung, James Sloand, Bruce I. Goldman
American Journal of Kidney Diseases. 2008-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: